For Generic Manufactures, New Medicare Drug Pricing Demo Is a Dud

 
• By Sarah Karlin-Smith
  
Dollars & Pills
CMS announces potential list of generics for proposed Part D demonstration

More from Drug Pricing

More from Generics Bulletin